Insider Cluster (8 insiders) ·Filed May 26, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 8 insiders, $1.7M total
Actionable Insight • Neutral

The cluster is small relative to market cap and largely tied to option exercises, making it a routine diversification event rather than a bearish signal. Monitor for any material news (pipeline updates, regulatory filings) that could explain the timing, but no immediate trading action is warranted based on this cluster alone.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +23.48% at T+60d
NEUTRAL call ✓ call won +23.48% · α vs SPY +21.60% · entry $29.47 → $36.39
Entry anchored
May 26, 2026
via day open
T+1d
+1.32%
call +1.32% · α +0.77%
$29.86
settled 4mo ago
T+5d
+2.27%
call +2.27% · α +1.80%
$30.14
settled 4mo ago
T+20d
+13.00%
call +13.00% · α +14.90%
$33.30
settled 3mo ago
T+60d
+23.48%
call +23.48% · α +21.60%
$36.39
settled 6w ago

Price Chart

Loading chart...

Executive Summary

A cluster of 8 Pharvaris insiders, including the CEO, CFO, and CCO, sold a total of $1.73M in open-market sales over a 7-day window. While the dollar amount is modest relative to the $2.1B market cap (~0.08%), the breadth of C-suite participation and the absence of any open-market buying is notable. The sales follow option exercises and coincide with the stock trading near recent highs, suggesting routine portfolio diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.7M
Insiders
8

Key Facts

  • 8 insiders sold a total of $1.73M in open-market sales over 7 days (May 14-21, 2026)
  • CFO David Nassif sold $303K, CEO Berndt Modig sold $67K, CCO Wim Souverijns sold $299K
  • Total sales represent ~0.08% of Pharvaris' $2.1B market cap — below the 0.1% materiality threshold
  • Several sales were preceded by option exercises at $0 or $8.05 strike prices, indicating tax-motivated selling
  • No open-market purchases were reported in the cluster window
  • The stock has a 90% bullish analyst consensus and recent insider activity (30d) totaled $1.1M in sales

Financial Impact

Total insider sales of $1.73M, or ~0.08% of market cap

insider ownershipfloat

Risk Factors

  • Insider sales could accelerate if the stock continues to rally, creating overhang
  • Lack of insider buying at current levels may indicate management sees limited near-term upside
  • Biotech sector volatility could amplify any negative read-through from insider activity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1779832444919
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 26, 2026